ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382770 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382770; 2) Community: the network communities that were significantly associated with the response to NSC 382770; 3) Molecule: the relationships between components within communities and NSC 382770; 4) MDR: the compounds that were significantly associated with the NSC 382770.

NSC Compound Enrichment Correlation
NSC 639174 Camptothecin Derivative 0.0382675857669585 0.18005587
NSC 639186 Raltitrexed 0.0382675857669585 0.25197381
NSC 645384 Null 0.0382675857669585 0.40785483
NSC 651694 Null 0.0382675857669585 0.098051366
NSC 653860 Null 0.0382675857669585 -0.08118653
NSC 657305 Null 0.0382675857669585 0.060803624
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0382675857669585 0.039334982
NSC 658368 Null 0.0382675857669585 0.18774199
NSC 659948 7-O-(2,3,6-Trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0382675857669585 0.065753932
NSC 659950 7-O-(3,4-Di-O-acetyl-2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexopyranosyl)-4-demethoxydaunomycinone 0.0382675857669585 0.092176886
Total:159  Current:127    [First] [Prev] [Next] [Last]